Pacs Group Inc (PACS) FinancialsPACSPacs Group Inc

PACS Group, Inc. (PACS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Medicaid, accounting for 39.3% of total sales, equivalent to $561.05M. Other significant revenue streams include Medicare and Managed care. Understanding this composition is critical for investors evaluating how PACS navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, PACS Group, Inc. maintains a gross margin of 15.66%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.28%, while the net margin is 5.35%. These profitability ratios, combined with a Return on Equity (ROE) of 28.08%, provide a clear picture of how effectively PACS converts its operational activities into shareholder value.

In the context of the broader market, PACS competes directly with industry leaders such as CHE and NHC. With a market capitalization of $7.04B, it holds a leading position in the sector. When comparing efficiency, PACS's gross margin of 15.66% stands against CHE's 30.37% and NHC's 37.98%. Such benchmarking helps identify whether PACS Group, Inc. is trading at a premium or discount relative to its financial performance.

Pacs Group has shown significant financial growth, with Q2 2026 revenue at $1.43 billion and a net income of $76.37 million, indicating strong operational performance. The gross margin has improved to 15.66%, reflecting better cost management and profitability.